Paper33809669
Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy.
Scala I and 7 others. Antioxidants (Basel), 2021. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy. Papers, record 33809669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33809669
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DSB.AD006.203, DSB.AD006.245 | Associazione A.M.A.R. Down-Onlus | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28029161 | Down syndrome and the complexity of genome dosage imbalance. | Nat Rev Genet | 2017 | https://conductscience.org/library/papers/28029161 | PubMed |
| 2 | 27302362 | Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27302362 | PubMed |
| 3 | 12534346 | The specificities of protein kinase inhibitors: an update. | Biochem J | 2003 | https://conductscience.org/library/papers/12534346 | PubMed |
| 4 | 21338338 | Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. | Biochem J | 2011 | https://conductscience.org/library/papers/21338338 | PubMed |
| 5 | 27457036 | Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. | Neuroscience | 2016 | https://conductscience.org/library/papers/27457036 | PubMed |
| 6 | 26363314 | Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. | Pharmacol Biochem Behav | 2015 | https://conductscience.org/library/papers/26363314 | PubMed |
| 7 | 33504019 | Autism Spectrum Disorder from the Womb to Adulthood: Suggestions for a Paradigm Shift. | J Pers Med | 2021 | https://conductscience.org/library/papers/33504019 | PubMed |
| 8 | 32893622 | Adducts Derived from (-)-Epigallocatechin Gallate-Amadori Rearrangement Products in Aqueous Reaction Systems: Characterization, Formation, and Thermolysis. | J Agric Food Chem | 2020 | https://conductscience.org/library/papers/32893622 | PubMed |
| 9 | 23291000 | Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23291000 | PubMed |
| 10 | 29961644 | Patterns of Dietary Supplement Use in Children with Down Syndrome. | J Pediatr | 2018 | https://conductscience.org/library/papers/29961644 | PubMed |
| 11 | 32796781 | Mitochondrial DNA Copy Number is Associated with Attention Deficit Hyperactivity Disorder. | Psychiatr Danub | 2020 | https://conductscience.org/library/papers/32796781 | PubMed |
| 12 | 20096765 | Different expression of alpha and beta mitochondrial estrogen receptors in the aging rat brain: interaction with respiratory complex V. | Exp Gerontol | 2010 | https://conductscience.org/library/papers/20096765 | PubMed |
| 13 | 19685005 | Function and regulation of Dyrk1A: towards understanding Down syndrome. | Cell Mol Life Sci | 2009 | https://conductscience.org/library/papers/19685005 | PubMed |
| 14 | 29765861 | Mitochondrial Metabolism-Mediated Regulation of Adult Neurogenesis. | Brain Plast | 2017 | https://conductscience.org/library/papers/29765861 | PubMed |
| 15 | 26500515 | Timing of therapies for Down syndrome: the sooner, the better. | Front Behav Neurosci | 2015 | https://conductscience.org/library/papers/26500515 | PubMed |
| 16 | 30268771 | DYRK1A and cognition: A lifelong relationship. | Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30268771 | PubMed |
| 17 | 26530987 | 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system. | J Bioenerg Biomembr | 2015 | https://conductscience.org/library/papers/26530987 | PubMed |
| 18 | 30615933 | Down syndrome: Neurobiological alterations and therapeutic targets. | Neurosci Biobehav Rev | 2019 | https://conductscience.org/library/papers/30615933 | PubMed |
| 19 | 27826066 | Plant polyphenols as natural drugs for the management of Down syndrome and related disorders. | Neurosci Biobehav Rev | 2016 | https://conductscience.org/library/papers/27826066 | PubMed |
| 20 | 31518035 | Mitigative effects of epigallocatechin gallate in terms of diminishing apoptosis and oxidative stress generated by the combination of lead and amyloid peptides in human neuronal cells. | J Biochem Mol Toxicol | 2019 | https://conductscience.org/library/papers/31518035 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42356315 | Endocrine and Digestive Disorders Arising in Childhood in Down Syndrome and Their Cross-Talk. | Nutrients | 2026 | https://conductscience.org/library/papers/42356315 | PubMed |
| 42072161 | Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to Interventions. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072161 | PubMed |
| 41498039 | Mitochondrial Dysfunction and Immune Cell Infiltration in Diabetic Kidney Disease: A Mendelian Randomization and Multiomics Study. | Mediators Inflamm | 2025 | https://conductscience.org/library/papers/41498039 | PubMed |
| 41484421 | Cognitive and transcriptomic effects of Epigallocatechin gallate in fetal alcohol spectrum disorders. | Sci Rep | 2026 | https://conductscience.org/library/papers/41484421 | PubMed |
| 37900285 | Insights from the protein interaction Universe of the multifunctional "Goldilocks" kinase DYRK1A. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37900285 | PubMed |
| 37569863 | Brain Mitochondrial Bioenergetics in Genetic Neurodevelopmental Disorders: Focus on Down, Rett and Fragile X Syndromes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569863 | PubMed |
| 37237934 | Effect of Postnatal Epigallocatechin-Gallate Treatment on Cardiac Function in Mice Prenatally Exposed to Alcohol. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37237934 | PubMed |
| 35889838 | Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome? | Nutrients | 2022 | https://conductscience.org/library/papers/35889838 | PubMed |
| 35631180 | Catechins as a Potential Dietary Supplementation in Prevention of Comorbidities Linked with Down Syndrome. | Nutrients | 2022 | https://conductscience.org/library/papers/35631180 | PubMed |
| 35600880 | Exploring the Therapeutic Potential of Phytochemicals in Alzheimer's Disease: Focus on Polyphenols and Monoterpenes. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35600880 | PubMed |
| 35052567 | Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/35052567 | PubMed |
| 34054222 | Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. | Trends Food Sci Technol | 2021 | https://conductscience.org/library/papers/34054222 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33809669
GET https://conductscience.org/api/papers/v1/33809669/references?page=2